Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2011 (2011), Article ID 917941, 9 pages
http://dx.doi.org/10.1155/2011/917941
Review Article

Radiation Proctitis: Current Strategies in Management

Division of Colon and Rectal Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School Boston, 330 Brookline Avenue, Stoneman 9, Boston, MA 02215, USA

Received 31 January 2011; Revised 15 June 2011; Accepted 23 August 2011

Academic Editor: Jean S. Wang

Copyright © 2011 Nhue L. Do et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Xiao and M. H. Whitnall, “Pharmacological countermeasures for the acute radiation syndrome,” Current Molecular Pharmacology, vol. 2, no. 1, pp. 122–133, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Denton, A. Forbes, J. Andreyev, and E. J. Maher, “Non surgical interventions for late radiation proctitis in patients who have received radical radiotherapy to the pelvis,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD003455, 2002. View at Google Scholar
  3. T. Terasawa, T. Dvorak, S. Ip, G. Raman, J. Lau, and T. A. Trikalinos, “Systematic review: charged-particle radiation therapy for cancer,” Annals of Internal Medicine, vol. 151, no. 8, pp. 556–565, 2009. View at Google Scholar · View at Scopus
  4. E. Melian, G. S. Mageras, Z. Fuks et al., “Variation in prostate position quantitation and implications for three- dimensional conformal treatment planning,” International Journal of Radiation Oncology Biology Physics, vol. 38, no. 1, pp. 73–81, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. B. A. Fraass, M. L. Kessler, D. L. McShan et al., “Optimization and clinical use of multisegment intensity-modulated radiation therapy for high-dose conformal therapy,” Seminars in Radiation Oncology, vol. 9, no. 1, pp. 60–77, 1999. View at Google Scholar · View at Scopus
  6. S. A. Shah, R. R. Cima, E. Benoit, E. L. Breen, and R. Bleday, “Rectal complications after prostate brachytherapy,” Diseases of the Colon and Rectum, vol. 47, no. 9, pp. 1487–1492, 2004. View at Publisher · View at Google Scholar · View at PubMed
  7. R. N. Lesperance, R. J. Kjorstadt, J. B. Halligan, and S. R. Steele, “Colorectal complications of external beam radiation versus brachytherapy for prostate cancer,” American Journal of Surgery, vol. 195, no. 5, pp. 616–620, 2008. View at Publisher · View at Google Scholar · View at PubMed
  8. T. E. Schultheiss, W. R. Lee, M. A. Hunt, A. L. Hanlon, R. S. Peter, and G. E. Hanks, “Late GI and GU complications in the treatment of prostate cancer,” International Journal of Radiation Oncology Biology Physics, vol. 37, no. 1, pp. 3–11, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. L. R. Coia, “Late effects of radiation therapy on the gastrointestinal tract,” International Journal of Radiation Oncology Biology Physics, vol. 31, no. 5, pp. 1213–1236, 1995. View at Publisher · View at Google Scholar
  10. C. J. Beard, K. J. Propert, P. P. Rieker et al., “Complications after treatment with external-beam irradiation in early- stage prostate cancer patients: a prospective multiinstitutional outcomes study,” Journal of Clinical Oncology, vol. 15, no. 1, pp. 223–229, 1997. View at Google Scholar · View at Scopus
  11. M. V. Pilepich, J. M. Krall, and W. T. Sause, “Correlation of radiotherapeutic parameters and treatment related morbidity in carcinoma of the prostate—analysis of RTOG study 75-06,” International Journal of Radiation Oncology Biology Physics, vol. 13, no. 3, pp. 351–357, 1987. View at Google Scholar
  12. M. J. Zelefsky, Z. Fuks, M. Hunt et al., “High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients,” International Journal of Radiation Oncology Biology Physics, vol. 53, no. 5, pp. 1111–1116, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. M. J. Zelefsky, E. J. Levin, M. Hunt et al., “Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer,” International Journal of Radiation Oncology Biology Physics, vol. 70, no. 4, pp. 1124–1129, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. A. L. Zietman, K. Bae, J. D. Slater et al., “Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09,” Journal of Clinical Oncology, vol. 28, no. 7, pp. 1106–1111, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. S. I. Zeitlin, J. Sherman, A. Raboy, G. Lederman, and P. Albert, “High dose combination radiotherapy for the treatment of localized prostate cancer,” Journal of Urology, vol. 160, no. 1, pp. 91–96, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. A. S. Denton, H. J. N. Andreyev, A. Forbes, and E. J. Maher, “Systematic review for non-surgical interventions for the management of late radiation proctitis,” British Journal of Cancer, vol. 87, no. 2, pp. 134–143, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. G. Cotti, V. Seid, S. Araujo, A. H. Souza, D. R. Kiss, and A. Habr-Gama, “Conservative therapies for hemorrhagic radiation proctitis: a review,” Revista do Hospital das Clínicas., vol. 58, no. 5, pp. 284–292, 2003. View at Google Scholar · View at Scopus
  18. P. P. Tagkalidis and J. J. Tjandra, “Chronic radiation proctitis,” ANZ Journal of Surgery, vol. 71, no. 4, pp. 230–237, 2001. View at Google Scholar · View at Scopus
  19. M. Kennedy, K. Bruninga, E. A. Mutlu, J. Losurdo, S. Choudhary, and A. Keshavarzian, “Successful and sustained treatment of chronic radiation proctitis with antioxidant vitamins E and C,” American Journal of Gastroenterology, vol. 96, no. 4, pp. 1080–1084, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. C. G. Willett, C. J. Ooi, A. L. Zietman et al., “Acute and late toxicity of patients with inflammatory bowel disease undergoing irradiation for abdominal and pelvic neoplasms,” International Journal of Radiation Oncology Biology Physics, vol. 46, no. 4, pp. 995–998, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Phan, D. A. Swanson, L. B. Levy, R. J. Kudchadker, T. L. Bruno, and S. J. Frank, “Late rectal complications after prostate brachytherapy for localized prostate cancer,” Cancer, vol. 115, no. 9, pp. 1827–1839, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. R. Hoffman, M. L. Welton, B. Klencke, V. Weinberg, and R. Krieg, “The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer,” International Journal of Radiation Oncology Biology Physics, vol. 44, no. 1, pp. 127–131, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Housri, R. Yarchoan, and A. Kaushal, “Radiotherapy for patients with the human immunodeficiency virus: are special precautions necessary?” Cancer, vol. 116, no. 2, pp. 273–283, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. T. Kertesz, M. K.A. Herrmann, A. Zapf et al., “Effect of a prostaglandin—given rectally for prevention of radiation-induced acute proctitis—on late rectal toxicity: results of a phase III randomized, placebo-controlled, double-blind study,” Strahlentherapie und Onkologie, vol. 185, no. 9, pp. 596–602, 2009. View at Publisher · View at Google Scholar · View at PubMed
  25. A. Kneebone, H. Mameghan, T. Bolin et al., “Effect of oral sucralfate on late rectal injury associated with radiotherapy for prostate cancer: a double-blind, randomized trial,” International Journal of Radiation Oncology Biology Physics, vol. 60, no. 4, pp. 1088–1097, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. P. C. O'Brien, C. I. Franklin, M. G. Poulsen, D. J. Joseph, N. S. Spry, and J. W. Denham, “Acute symptoms, not rectally administered sucralfate, predict for late radiation proctitis: longer term follow-up of a phase III trial—Trans-Tasman Radiation Oncology Group,” International Journal of Radiation Oncology Biology Physics, vol. 54, no. 2, pp. 442–449, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Hovdenak, H. Sørbye, and O. Dahl, “Sucralfate does not ameliorate acute radiation proctitis: randomised study and meta-analysis,” Clinical Oncology, vol. 17, no. 6, pp. 485–491, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Liu, Y. Liu, S. He, Z. Zhang, and M. M. Kligerman, “Use of radiation with or without WR-2721 in advanced rectal cancer,” Cancer, vol. 69, no. 11, pp. 2820–2825, 1992. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Athanassiou, D. Antonadou, N. Coliarakis et al., “Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: results of a randomized trial,” International Journal of Radiation Oncology Biology Physics, vol. 56, no. 4, pp. 1154–1160, 2003. View at Publisher · View at Google Scholar
  30. D. M. Keefe, M. M. Schubert, L. S. Elting et al., “Updated clinical practice guidelines for the prevention and treatment of mucositis,” Cancer, vol. 109, no. 5, pp. 820–831, 2007. View at Publisher · View at Google Scholar · View at PubMed
  31. M. A. Peppercorn, “Sulfasalazine. Pharmacology, clinical use toxicity, and related new drug development,” Annals of Internal Medicine, vol. 101, no. 3, pp. 377–386, 1984. View at Google Scholar · View at Scopus
  32. C. P. Rains, S. Noble, and D. Faulds, “Sulfasalazine: a review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis,” Drugs, vol. 50, no. 1, pp. 137–156, 1995. View at Google Scholar · View at Scopus
  33. U. Klotz, K. Maier, C. Fischer, and K. Heinkel, “Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease,” New England Journal of Medicine, vol. 303, no. 26, pp. 1499–1502, 1980. View at Google Scholar · View at Scopus
  34. R. Kochhar, F. Patel, S. C. Scharma et al., “Radiation-induced proctosigmoiditis: prospective, randomized, double-blind controlled trial of oral sulfasalazine plus rectal steroids versus rectal sucralfate,” Digestive Diseases and Sciences, vol. 36, no. 1, pp. 103–107, 1991. View at Google Scholar · View at Scopus
  35. L. A. Schwiebert, L. A. Beck, C. Stellato, C. A. Bickel, B. S. Bochner, and R. P. Schleimer, “Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions,” Journal of Allergy and Clinical Immunology, vol. 97, no. 1, pp. 143–152, 1996. View at Publisher · View at Google Scholar · View at Scopus
  36. C. D. Freeman, N. E. Klutman, and K. C. Lamp, “Metronidazole. A therapeutic review and update,” Drugs, vol. 54, no. 5, pp. 679–708, 1997. View at Google Scholar · View at Scopus
  37. J. Cavcic, J. Turcic, P. Martinac et al., “Metronidazole in the treatment of chronic radiation proctitis: clinical trial,” Croatian Medical Journal, vol. 41, no. 3, pp. 314–318, 2000. View at Google Scholar
  38. V. Veerasarn, W. Boonnuch, and C. Kakanaporn, “A phase II study to evaluate WF10 in patients with late hemorrhagic radiation cystitis and proctitis,” Gynecologic Oncology, vol. 100, no. 1, pp. 179–184, 2006. View at Publisher · View at Google Scholar · View at PubMed
  39. B. F. McGraw and E. G. Caldwell, “Sucralfate,” Drug Intelligence and Clinical Pharmacy, vol. 15, no. 7-8, pp. 578–580, 1981. View at Google Scholar · View at Scopus
  40. R. Nagashima, “Mechanisms of action of sucralfate,” Journal of Clinical Gastroenterology, vol. 3, supplement 2, pp. 117–127, 1981. View at Google Scholar · View at Scopus
  41. G. Sanguineti, P. Franzone, M. Marcenaro, F. Foppiano, and V. Vitale, “Sucralfate versus mesalazine versus hydrocortisone in the prevention of acute radiation proctitis during conformal radiotherapy for prostate carcinoma: a randomized study,” Strahlentherapie und Onkologie, vol. 179, no. 7, pp. 464–470, 2003. View at Google Scholar · View at Scopus
  42. P. W. Grigsby, M. V. Pilepich, and C. L. Parsons, “Preliminary results of a phase I/II study of sodium pentosanpolysulfate in the treatment of chronic radiation-induced proctitis,” American Journal of Clinical Oncology, vol. 13, no. 1, pp. 28–31, 1990. View at Google Scholar · View at Scopus
  43. B. Darcy-Vrillon, C. Cherbuy, M. T. Morel, M. Durand, and P. H. Duée, “Short chain fatty acid and glucose metabolism in isolated pig colonocytes: modulation by NH4+,” Molecular and Cellular Biochemistry, vol. 156, no. 2, pp. 145–151, 1996. View at Publisher · View at Google Scholar · View at Scopus
  44. P. H. Duée, B. Darcy-Vrillon, F. Blachier, and M. T. Morel, “Fuel selection in intestinal cells,” Proceedings of the Nutrition Society, vol. 54, no. 1, pp. 83–94, 1995. View at Google Scholar · View at Scopus
  45. C. Aalkjaer, “Short chained fatty acids and the colon: how do they cause vasodilatation?” Journal of Physiology, vol. 538, no. 3, p. 674, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. N. A. Talley, F. Chen, D. King, M. Jones, and N. J. Talley, “Short-chain fatty acids in the treatment of radiation proctitis: a randomized, double-blind, placebo-controlled, cross-over pilot trial,” Diseases of the Colon and Rectum, vol. 40, no. 9, pp. 1046–1050, 1997. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Pinto, P. Fidalgo, M. Cravo et al., “Short chain fatty acids are effective in short-term treatment of chronic radiation proctitis: randomized, double-blind, controlled trial,” Diseases of the Colon and Rectum, vol. 42, no. 6, pp. 788–796, 1999. View at Publisher · View at Google Scholar · View at Scopus
  48. R. Al-Sabbagh, F. A. Sinicrope, J. H. Sellin, Y. Shen, and L. Roubein, “Evaluation of short-chain fatty acid enemas: treatment of radiation proctitis,” Diseases of the Colon & Rectum, vol. 40, no. 9, pp. 1046–1050, 1997. View at Google Scholar
  49. J. J. Feldmeier and N. B. Hampson, “A systematic review of the literature reporting the application of hyperbaric oxygen prevention and treatment of delayed radiation injuries: an evidence based approach,” Undersea and Hyperbaric Medicine, vol. 29, no. 1, pp. 4–30, 2002. View at Google Scholar · View at Scopus
  50. R. E. Marx, “A new concept in the treatment of osteoradionecrosis,” Journal of Oral and Maxillofacial Surgery, vol. 41, no. 6, pp. 351–357, 1983. View at Google Scholar · View at Scopus
  51. M. H. Bennett, J. Feldmeier, N. Hampson, R. Smee, and C. Milross, “Hyperbaric oxygen therapy for late radiation tissue injury,” Cochrane Database of Systematic Reviews, no. 3, Article ID CD005005, 2005. View at Google Scholar
  52. R. E. Clarke, L. M. C. Tenorio, J. R. Hussey et al., “Hyperbaric oxygen treatment of chronic refractory radiation proctitis: a randomized and controlled double-blind crossover trial with long-term follow-up,” International Journal of Radiation Oncology Biology Physics, vol. 72, no. 1, pp. 134–143, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. E. D. Ehrenpreis, A. Jani, J. Levitsky, J. Ahn, and J. Hong, “A prospective, randomized, double-blind, placebo-controlled trial of retinol palmitate (vitamin A) for symptomatic chronic radiation proctopathy,” Diseases of the Colon and Rectum, vol. 48, no. 1, pp. 1–8, 2005. View at Google Scholar · View at Scopus
  54. P. Patel, G. Subhas, A. Gupta, Y. J. Chang, V. K. Mittal, and A. McKendrick, “Oral vitamin A enhances the effectiveness of formalin 8% in treating chronic hemorrhagic radiation proctopathy,” Diseases of the Colon and Rectum, vol. 52, no. 9, pp. 1605–1609, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. E. M. Haas, H. R. Bailey, and I. Farragher, “Application of 10 percent formalin for the treatment of radiation-induced hemorrhagic proctitis,” Diseases of the Colon and Rectum, vol. 50, no. 2, pp. 213–217, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  56. S. Parikh, C. Hughes, E. P. Salvati et al., “Treatment of hemorrhagic radiation proctitis with 4 percent formalin,” Diseases of the Colon and Rectum, vol. 46, no. 5, pp. 596–600, 2003. View at Publisher · View at Google Scholar · View at Scopus
  57. S. F. Counter, D. P. Froese, and M. J. Hart, “Prospective evaluation of formalin therapy for radiation proctitis,” American Journal of Surgery, vol. 177, no. 5, pp. 396–398, 1999. View at Publisher · View at Google Scholar · View at Scopus
  58. V. Mathai and F. Seow-Choen, “Endoluminal formalin therapy for haemorrhagic radiation proctitis,” British Journal of Surgery, vol. 82, no. 2, p. 190, 1995. View at Publisher · View at Google Scholar · View at Scopus
  59. J. J. Tjandra and S. Sengupta, “Argon plasma coagulation is an effective treatment for refractory hemorrhagic radiation proctitis,” Diseases of the Colon and Rectum, vol. 44, no. 12, pp. 1759–1765, 2001. View at Google Scholar · View at Scopus
  60. A. C. Fantin, J. Binek, W. R. Suter, and C. Meyenberger, “Argon beam coagulation for treatment of symptomatic radiation-induced proctitis,” Gastrointestinal Endoscopy, vol. 49, no. 4, pp. 515–518, 1999. View at Publisher · View at Google Scholar · View at Scopus
  61. R. A. Silva, A. J. Correia, L. M. Dias, H. L. Viana, and R. L. Viana, “Argon plasma coagulation therapy for hemorrhagic radiation proctosigmoiditis,” Gastrointestinal Endoscopy, vol. 50, no. 2, pp. 221–224, 1999. View at Publisher · View at Google Scholar · View at Scopus
  62. M. P. Swan, G. T. C. Moore, W. Sievert, and D. A. Devonshire, “Efficacy and safety of single-session argon plasma coagulation in the management of chronic radiation proctitis,” Gastrointestinal Endoscopy, vol. 72, no. 1, pp. 150–154, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. C. S. Higuera, M. I. M. Arribas, S. J. R. Gómez, A. P. Villoria, J. M. Moreno, and A. B. González, “Efficacy and safety of argon plasma coagulation for the treatment of hemorrhagic radiation proctitis,” Revista Espanola de Enfermedades Digestivas, vol. 96, no. 11, pp. 758–764, 2004. View at Google Scholar · View at Scopus
  64. T. J. Alexander and R. M. Dwyer, “Endoscopic Nd:YAG laser treatment of severe radiation injury of the lower gastrointestinal tract: long-term follow-up,” Gastrointestinal Endoscopy, vol. 34, no. 5, pp. 407–411, 1988. View at Google Scholar · View at Scopus
  65. M. Ventrucci, M. P. Di Simone, P. Giulietti, and G. De Luca, “Efficacy and safety of Nd:YAG laser for the treatment of bleeding from radiation proctocolitis,” Digestive and Liver Disease, vol. 33, no. 3, pp. 230–233, 2001. View at Google Scholar · View at Scopus
  66. S. W. Jao, R. W. Beart, and L. L. Gunderson, “Surgical treatment of radiation injuries of the colon and rectum,” American Journal of Surgery, vol. 151, no. 2, pp. 272–277, 1986. View at Google Scholar · View at Scopus
  67. J. Ayerdi, K. Moinuddeen, A. Loving, J. Wiseman, and N. Deshmukh, “Diverting loop colostomy for the treatment of refractory gastrointestinal bleeding secondary to radiation proctitis,” Military Medicine, vol. 166, no. 12, pp. 1091–1093, 2001. View at Google Scholar · View at Scopus
  68. V. E. Pricolo and P. C. Shellito, “Surgery for radiation injury to the large intestine: variables influencing outcome,” Diseases of the Colon and Rectum, vol. 37, no. 7, pp. 675–684, 1994. View at Publisher · View at Google Scholar · View at Scopus
  69. P. F. Anseline, I. C. Lavery, and V. W. Fazio, “Radiation injury of the rectum. Evaluation of surgical treatment,” Annals of Surgery, vol. 194, no. 6, pp. 716–724, 1981. View at Google Scholar · View at Scopus
  70. M. E. Lucarotti, R. A. Mountford, and D. C. C. Bartolo, “Surgical management of intestinal radiation injury,” Diseases of the Colon and Rectum, vol. 34, no. 10, pp. 865–869, 1991. View at Google Scholar · View at Scopus
  71. A. M. Nieder, M. P. Porter, and M. S. Soloway, “Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study,” Journal of Urology, vol. 180, no. 5, pp. 2005–2010, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus